Njølstad I - Search Results

1

Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up.

Grimnes G, Emaus N, Joakimsen RM, Figenschau Y, Jenssen T, Njølstad I, Schirmer H, Jorde R. Grimnes G, et al. Among authors: njolstad i. Diabet Med. 2010 Oct;27(10):1107-15. doi: 10.1111/j.1464-5491.2010.03092.x. Diabet Med. 2010. PMID: 20854377

2

Body height, cardiovascular risk factors, and risk of stroke in middle-aged men and women. A 14-year follow-up of the Finnmark Study.

Njølstad I, Arnesen E, Lund-Larsen PG. Njølstad I, et al. Circulation. 1996 Dec 1;94(11):2877-82. doi: 10.1161/01.cir.94.11.2877. Circulation. 1996. PMID: 8941116

3

Sex differences in risk factors for clinical diabetes mellitus in a general population: a 12-year follow-up of the Finnmark Study.

Njølstad I, Arnesen E, Lund-Larsen PG. Njølstad I, et al. Am J Epidemiol. 1998 Jan 1;147(1):49-58. doi: 10.1093/oxfordjournals.aje.a009366. Am J Epidemiol. 1998. PMID: 9440398

4

Physical activity improves the metabolic risk profiles in men and women: the Tromsø Study.

Thune I, Njølstad I, Løchen ML, Førde OH. Thune I, et al. Among authors: njolstad i. Arch Intern Med. 1998 Aug 10-24;158(15):1633-40. doi: 10.1001/archinte.158.15.1633. Arch Intern Med. 1998. PMID: 9701097

5

Cardiovascular diseases and diabetes mellitus in different ethnic groups: the Finnmark study.

Njølstad I, Arnesen E, Lund-Larsen PG. Njølstad I, et al. Epidemiology. 1998 Sep;9(5):550-6. Epidemiology. 1998. PMID: 9730036

6

Increase in weight in all birth cohorts in a general population: The Tromsø Study, 1974-1994.

Jacobsen BK, Njølstad I, Thune I, Wilsgaard T, Løchen ML, Schirmer H. Jacobsen BK, et al. Among authors: njolstad i. Arch Intern Med. 2001 Feb 12;161(3):466-72. doi: 10.1001/archinte.161.3.466. Arch Intern Med. 2001. PMID: 11176774

7

Tracking of cardiovascular risk factors: the Tromsø study, 1979-1995.

Wilsgaard T, Jacobsen BK, Schirmer H, Thune I, Løchen ML, Njølstad I, Arnesen E. Wilsgaard T, et al. Among authors: njolstad i. Am J Epidemiol. 2001 Sep 1;154(5):418-26. doi: 10.1093/aje/154.5.418. Am J Epidemiol. 2001. PMID: 11532783

8

Cardiovascular risk factors, change in risk factors over 7 years, and the risk of clinical diabetes mellitus type 2. The Tromsø study.

Jacobsen BK, Bønaa KH, Njølstad I. Jacobsen BK, et al. Among authors: njolstad i. J Clin Epidemiol. 2002 Jul;55(7):647-53. doi: 10.1016/s0895-4356(02)00404-3. J Clin Epidemiol. 2002. PMID: 12160912

9

Does implementation of the European guidelines based on the SCORE model double the number of Norwegian adults who need cardiovascular drugs for primary prevention? The Tromsø study 2001.

Hartz I, Njølstad I, Eggen AE. Hartz I, et al. Among authors: njolstad i. Eur Heart J. 2005 Dec;26(24):2673-80. doi: 10.1093/eurheartj/ehi556. Epub 2005 Oct 4. Eur Heart J. 2005. PMID: 16204260

10

Homocysteine lowering and cardiovascular events after acute myocardial infarction.

Bønaa KH, Njølstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K; NORVIT Trial Investigators. Bønaa KH, et al. Among authors: njolstad i. N Engl J Med. 2006 Apr 13;354(15):1578-88. doi: 10.1056/NEJMoa055227. Epub 2006 Mar 12. N Engl J Med. 2006. PMID: 16531614 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page